Nexus Surgical and Medicare Limited
Bombay Stock ExchangeTotal Valuation
Nexus Surgical and Medicare Limited carries a market capitalization of 109.44M, placing it among publicly traded companies globally. Its enterprise value stands at 81.95M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 109.44M |
| Enterprise Value | 81.95M |
Share Statistics
Nexus Surgical and Medicare Limited currently has 5.47M shares outstanding.
| Shares Outstanding | 5.47M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Nexus Surgical and Medicare Limited trades at a trailing price-to-earnings ratio of 11.87. The price-to-sales ratio is 1.11, and the price-to-book ratio stands at 1.60.
| PE Ratio | 11.87 |
| PS Ratio | 1.11 |
| PB Ratio | 1.60 |
| P/TBV Ratio | 4.86 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
The EV/Sales ratio of 1.04 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 8.54 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.04 |
| EV / EBITDA | 8.54 |
| EV / EBIT | 8.54 |
| EV / FCF | N/A |
Financial Position
Nexus Surgical and Medicare Limited maintains a current ratio of 1.96, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.96 |
| Quick Ratio | 0.30 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
Nexus Surgical and Medicare Limited posts a return on equity of 22.53 and a return on invested capital of 49.61.
| Return on Equity (ROE) | 22.53 |
| Return on Assets (ROA) | 24.85 |
| Return on Invested Capital (ROIC) | 49.61 |
| Return on Capital Employed (ROCE) | 22.53 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 6.96 |
Taxes
Over the trailing twelve months, Nexus Surgical and Medicare Limited has paid 2.51M in income taxes, reflecting an effective tax rate of 25.46.
| Income Tax | 2.51M |
| Effective Tax Rate | 25.46 |
Stock Price Statistics
Nexus Surgical and Medicare Limited's stock has gained approximately 13.50738% over the past 52 weeks. The 50-day moving average sits at 20.52, while the 200-day moving average is 18.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 13.50738% |
| 50-Day Moving Average | 20.52 |
| 200-Day Moving Average | 18.00 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Nexus Surgical and Medicare Limited generated 78.68M in revenue and converted that into 7.36M in net income, yielding earnings per share of 1.35. EBITDA reached 9.59M, while operating income came in at 9.59M.
| Revenue | 78.68M |
| Gross Profit | 51.05M |
| Operating Income | 9.59M |
| Pretax Income | 9.88M |
| Net Income | 7.36M |
| EBITDA | 9.59M |
| EBIT | 9.59M |
| Earnings Per Share (EPS) | 1.35 |
Balance Sheet
Total book value stands at 54.72M, with working capital of 17.72M providing operational flexibility.
| Cash & Cash Equivalents | 5.47M |
| Total Debt | N/A |
| Net Debt | -5.04M |
| Equity (Book Value) | 54.72M |
| Book Value Per Share | 10.03 |
| Working Capital | 17.72M |
Margins
Nexus Surgical and Medicare Limited operates with a gross margin of 64.88, reflecting its pricing power and cost economics. The operating margin of 12.19 and net profit margin of 9.36 provide insight into operational efficiency.
| Gross Margin | 64.88 |
| Operating Margin | 12.19 |
| Pretax Margin | 12.55 |
| Profit Margin | 9.36 |
| EBITDA Margin | 12.19 |
Scores
Nexus Surgical and Medicare Limited posts an Altman Z-Score of 6.44, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 6.44 |